Dr. Tashko’s 3D medical illustration showing the brain, airway, and heart connection during sleep, highlighting how obstructive sleep apnea disrupts oxygen flow. The glowing red regions trace the cascade from airway collapse to brain and cardiovascular strain, symbolizing the systemic consequences of untreated sleep apnea on overall health.

Sleep apnea is far more than loud snoring or restless nights. It is a chronic condition that disrupts breathing during sleep, lowering oxygen levels and straining nearly every system in the body. Over time, untreated sleep apnea drives cardiovascular, metabolic, and cognitive decline in ways that may not be obvious until other health issues appear.

Understanding Sleep Apnea

Sleep apnea occurs when breathing repeatedly stops and starts during sleep. The most common form, obstructive sleep apnea (OSA), happens when the upper airway collapses. A less common form, central sleep apnea (CSA), arises when the brain fails to send proper signals to the breathing muscles.

Each pause in breathing, known as an apnea, can last ten seconds or longer and repeat hundreds of times a night. These interruptions break the deep stages of sleep and trigger sharp drops in oxygen. The body responds by raising heart rate, blood pressure, and stress hormones, creating nightly surges of physiologic strain.

How It Affects the Heart and Blood Vessels

Untreated sleep apnea places constant pressure on the cardiovascular system. Every apnea episode acts like a stress test, activating the sympathetic nervous system and increasing the risk of:

  • Resistant hypertension that persists despite several medications
  • Heart rhythm irregularities, especially atrial fibrillation
  • Thickening of the heart muscle from chronic strain
  • Greater likelihood of heart attack, stroke, and heart failure

Studies show that treating OSA with continuous or automatic positive airway pressure (CPAP or APAP) or oral devices lowers blood pressure, stabilizes heart rhythm, and protects blood vessels. This makes sleep apnea treatment an essential part of cardiovascular prevention.

Connection to Metabolic and Hormonal Health

Interrupted sleep alters how the body handles sugar and fat. Oxygen drops raise insulin resistance and promote inflammation. Many people with type 2 diabetes or prediabetes unknowingly have underlying sleep apnea, which worsens blood sugar control and weight gain.

Sleep deprivation also affects appetite hormones. Ghrelin increases while leptin decreases, which leads to stronger hunger cues and slower metabolism. Extra weight around the neck and abdomen then worsens airway collapse, creating a self-reinforcing cycle.

Common patterns seen in patients with untreated OSA include:

  • Worsening blood sugar despite good medication adherence
  • Elevated triglycerides or fatty liver
  • Fatigue and weight gain unrelated to diet
  • Elevated morning cortisol or stress markers

When sleep apnea is treated, glucose regulation often improves, and metabolic inflammation begins to quiet.

The Brain and Cognitive Effects

Healthy sleep restores the brain, consolidates memory, and clears toxins. Apnea fragments this process, causing lapses in concentration and unstable mood. Many people describe “brain fog” or morning grogginess that seems unrelated to lifestyle.

Chronic oxygen deprivation can accelerate brain aging. Studies have linked severe OSA to smaller hippocampal volume, which affects memory and learning. Treating apnea restores oxygen flow, deep sleep, and mental clarity. Patients often notice sharper focus and steadier emotions within weeks.

The Role of Inflammation

Each night of untreated apnea produces cycles of oxidative stress and inflammation. Over time, this ongoing burden can contribute to atherosclerosis, fatty liver disease, and other chronic illnesses. Higher levels of inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6) are often found in patients with moderate or severe sleep apnea.

Restoring steady oxygen during sleep helps break this cycle, lowering inflammation and protecting long-term vascular health.

Impact on Hormones and Sexual Health

Sleep is a natural regulator of hormone balance. Repeated oxygen drops interfere with testosterone production in men and ovulatory cycles in women. The result can be low libido, erectile dysfunction, or menstrual irregularities.

For men on testosterone replacement therapy (TRT), untreated sleep apnea increases cardiovascular risk and may blunt therapy benefits. Once sleep apnea is addressed, hormone rhythms stabilize, and sexual health often improves.

Patient Case Highlights

  • Case 1: The Resistant Hypertensive
    A 52-year-old man had blood pressure readings around 160/100 mmHg despite using three medications. After reporting loud snoring and fatigue, a sleep study revealed severe OSA. With APAP therapy, his average blood pressure fell to 130/80 mmHg, and one medication was stopped.
  • Case 2: The Fatigued Executive
    A 46-year-old woman struggled with poor focus and afternoon exhaustion. Her thyroid function was normal, but her insulin was mildly elevated. Overnight monitoring confirmed moderate OSA. Two months of therapy brought steady energy and a 25 percent improvement in fasting insulin.
  • Case 3: The Metabolic Overlap
    A 60-year-old man with obesity and type 2 diabetes found that his glucose control worsened despite consistent treatment. Sleep testing confirmed severe OSA. After six months of CPAP, his A1c dropped from 8.1% to 6.9%, and he began losing weight without medication changes.
  • Case 4: The Silent Heart Risk
    A 67-year-old woman with atrial fibrillation experienced frequent recurrences after ablation. Evaluation uncovered untreated OSA. Once therapy began, her rhythm stabilized, and episodes became rare.
  • Case 5: The Cognitive Decline
    A 70-year-old man experienced memory lapses and morning confusion. Neurological testing was unrevealing. A sleep study identified severe OSA. With treatment, his mood lifted, attention improved, and memory complaints faded.

Summary Table

System AffectedConsequences of Untreated Sleep Apnea
CardiovascularHypertension, arrhythmia, heart failure, stroke
MetabolicInsulin resistance, weight gain, fatty liver
CognitiveMemory loss, poor concentration, mood changes
HormonalLow testosterone, menstrual irregularities
InflammatoryElevated CRP, vascular and liver damage

Path to Better Sleep and Health

Diagnosis begins with an in-home or in-lab sleep study. Treatment options include CPAP or APAP therapy, oral mandibular devices, and lifestyle changes such as weight loss, nasal optimization, and positional therapy. Some individuals benefit from upper airway stimulation, particularly when CPAP is not tolerated.

Addressing sleep apnea early prevents irreversible complications. Patients often feel renewed clarity and energy within weeks. Improved sleep can also enhance glucose control, mood stability, and daytime productivity.

At our practice in Montgomery County, Maryland, and through virtual care, we approach sleep apnea as both a respiratory and metabolic disorder. Treating it forms part of a comprehensive and thoughtful strategy to restore balance and protect long-term health from multiple angles.

Dr. Tashko

  1. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. Kapur VK, Auckley DH, Chowdhuri S, et al. Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine. 2017;13(3):479-504. doi:10.5664/jcsm.6506.
  2. Untreated Obstructive Sleep Apnea and the Risk for Serious Long-Term Adverse Outcomes: A Systematic Review. Kendzerska T, Mollayeva T, Gershon AS, et al. Sleep Medicine Reviews. 2014;18(1):49-59. doi:10.1016/j.smrv.2013.01.003.
  3. Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective. Young T, Peppard PE, Gottlieb DJ. American Journal of Respiratory and Critical Care Medicine. 2002;165(9):1217-39. doi:10.1164/rccm.2109080.
  4. Clinical Manifestations of Sleep Apnea. Stansbury RC, Strollo PJ. Journal of Thoracic Disease. 2015;7(9):E298-310. doi:10.3978/j.issn.2072-1439.2015.09.13.
  5. Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes. Tasali E, Pamidi S, Covassin N, Somers VK. Circulation Research. 2025;137(5):764-787. doi:10.1161/CIRCRESAHA.125.325676.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.